-
Clinical trials for antiviral drugs to treat COVID-19 have produced inconsistent results. New research led by Indiana University says the problem may come…
-
The Food and Drug Administration (FDA) has given emergency authorization to Eli Lilly for its COVID-19 antibody drug bamlanivimab.The Indianapolis-based…
-
The U.S. government has agreed to purchase 300,000 doses of Eli Lilly’s COVID-19 antibody treatment. It plans to pay $375 million for the vials of the…
-
Indiana’s State Health Commissioner says a COVID-19 vaccine could be available for some Hoosiers as early as mid to late November.Dr. Kris Box said…
-
Indianapolis-based Eli Lilly has ended testing its COVID-19 antibody therapy on hospitalized patients. Earlier this month, Eli Lilly temporarily suspended…
-
Johnson & Johnson’s COVID-19 vaccine trial is now on hold, after a participant became ill. Though pauses are not uncommon throughout the study or trial…